Highest-materiality recent filing
Modular Medical grants 15,892 stock options to CEO/CFO and COO
11,218 options awarded to Chairman/President/CFO Paul DiPerna.
Modular Medical prices $3.4M offering of 750k shares at $4.50 each
Gross proceeds ~$3.4M from sale of 750,000 shares; closing expected April 21, 2026.
Modular Medical regains Nasdaq minimum bid price compliance as of April 14, 2026
Received Nasdaq letter on April 15, 2026 confirming compliance with $1.00 minimum bid price requirement.
Modular Medical announces 1-for-30 reverse stock split to regain Nasdaq compliance
Reverse split effective 5:30am ET March 31, 2026; trading on split-adjusted basis under MODD symbol.
Modular Medical lays off 29% of workforce to cut annual costs by $3.4M
Layoff of 20 positions, representing ~29% of total workforce, effective March 12, 2026.
Modular Medical raises $12M via public offering of 68M shares and warrants
Gross proceeds ~$12M from sale of 68,098,000 shares (or pre-funded warrants) and 68,098,000 warrants at $0.1762/unit.
$350,000 revolving credit facility from CEO James E. Besser (Manchester Explorer, L.P.).
Authorized common shares increased from 100M to 250M (Proposal 3: 46.75M for, 5.04M against).
Modular Medical gets 180-day Nasdaq extension to June 29, 2026 to meet $1 bid price
Nasdaq granted 180-day extension under Rule 5810(c)(3)(A) after initial non-compliance notice on June 30, 2025.
Modular Medical raises $4.68M in underwritten public offering of stock and warrants
Offered 12,173,000 shares of common stock and warrants for 6,086,500 shares at combined price of $0.77 per unit.
Modular Medical induces warrant exercise for ~$3.7M gross; issues new warrants at premium
Warrant holders exercise ~5.5M shares at $0.68/share (10% discount to NOCP), raising $3.7M.
Modular Medical receives Nasdaq minimum bid price deficiency notice; 180-day cure period
Nasdaq notified Company of bid price deficiency: closing bid below $1.00 for 30 consecutive business days ending June 27, 2025.
Modular Medical appoints Jeff Goldberg, insulin delivery veteran, to Board
Appointed Jeff Goldberg to Board effective May 22, 2025.
Modular Medical raises ~$12.5M in private placement; funds MODD1 tubeless FDA submission
6,247,656 Units at $1.92/Unit; each Unit = 2 common shares + 1 warrant (exercise $1.12, 4-yr term).
All 7 director nominees elected (Duane DeSisto, Paul DiPerna, Steven Felsher, Morgan Frank, Philip Sheibley, Carmen Volkart, Ellen O'Connor Vos).
Modular Medical closes $8.2M public offering of 5.45M shares at $1.50/share
Offered 5,450,573 shares at $1.50/share; gross proceeds ~$8.2M before expenses.
Modular Medical gets FDA clearance for MODD1 insulin pump; launch expected early 2025
FDA cleared the MODD1 patch pump for all adults with Type 1 and Type 2 diabetes.
Milestone 2 options (FDA clearance by Aug 1, 2024) canceled on Aug 2, 2024; no clearance received.
Modular Medical raises salaries for President DiPerna & COO Schmid; grants 150k total options
Paul DiPerna's base salary increased from $300k to $360k retroactive April 1, 2024; title changed from CEO to President.
Modular Medical prices $10M public offering of 9.09M shares at $1.10 per share
Priced 9,090,910 shares at $1.10/share for $10M gross proceeds; over-allotment option for 1,321,989 additional shares.
Modular Medical increases authorized shares to 100M and suspends ATM equity program
Authorized common shares increased from 50M to 100M via charter amendment effective Feb 15, 2024.
Modular Medical submits MODD1 insulin pump to FDA for 510(k) clearance
Submitted MODD1 next-generation insulin pump to FDA for 510(k) clearance on Jan 19, 2024.
Modular Medical posts investor presentation; no specific new data provided in filing
Company posted an investor presentation on its website on December 26, 2023.
Modular Medical enters into $6.5M ATM sales agreement with Leerink Partners
Agreement allows sale of common stock from time to time for up to $6.5M in gross proceeds.
Modular Medical adopts FDA milestone bonus program; execs get options tied to MODD-1 clearance
CEO Besser receives 135,136 options for 510(k) submission by Jan 31, 2024; no options for clearance milestone.
Modular Medical appoints former Insulet CEO Duane DeSisto to board; William Febbo resigns
William Febbo resigned from the board effective July 5, 2023; not due to any disagreement.
Modular Medical prices upsized $9.4M public offering of units at $2.13/unit
Offering of 8,816,900 common shares and warrants for 4,408,450 shares at $2.13/unit yields gross $9.4M.
Shareholders elect all 7 directors and approve 2M-share equity plan increase
All seven director nominees elected: DiPerna, Febbo, Felsher, Frank, Sheibley, Volkart, O'Connor Vos.
Modular Medical enters 48-month lease for 24,000 sq ft in San Diego
Monthly base rent $36,000 for first 12 months, increasing 4% annually thereafter.
Modular Medical appoints Kevin Schmid as COO; $250K salary, 175K share option
Kevin Schmid appointed COO on July 21, 2022, effective immediately.
Modular Medical amends director comp plan; sets $10 floor for equity grants
Outside directors get $25k annual retainer for board service; $25k for chair; $5k for committee chair.
Modular Medical posts investor presentation on website; no new financial guidance disclosed
Company filed Form 8-K indicating it posted an investor presentation on June 13, 2022.
Modular Medical raises $8M via registered direct offering with Sio Capital Management
Offering: 449,438 shares at $4.45/share and pre-funded warrants for 1,348,314 shares at $4.44/warrant.
Modular Medical gets Oppenheimer waiver to file shelf registration before lock-up end
Oppenheimer & Co. waived lock-up to allow Modular Medical to file Form S-3 shelf registration for equity/debt securities.
Modular Medical posts investor presentation; no specific financial or operational updates disclosed
Company posted investor presentation to its website on February 24, 2022.
Modular Medical CEO resigns; largest shareholder's Jeb Besser appointed CEO; reaffirms FDA timeline
CEO Ellen O'Connor Vos resigned effective Feb 23, 2022; she remains on the board.
Modular Medical raises $15M in public offering, uplists to Nasdaq
Priced public offering of 2.5M units at $6.00/unit for gross proceeds of $15M; each unit = 1 share + 1 warrant.
Director Liam Burns resigns from Modular Medical Board; Board forms Nominating Committee
Liam Burns resigned as board member effective Dec 31, 2021; no disagreement with the Company.
Modular Medical appoints Steven Felsher and Philip Sheibley to Board of Directors
Effective November 29, 2021, appointed Steven Felsher and Philip Sheibley as independent directors.
Modular Medical announces 1-for-3 reverse stock split to meet Nasdaq listing price requirement
Reverse split ratio 1-for-3; effective Nov 29, 2021; trading symbol temporarily changes to MODDD.
Modular Medical secures $3M revolving credit facility at 12%; officers buy $250k in stock
CEO Ellen O'Connor Vos and Chairman Paul DiPerna purchased 92,592 shares at $2.70/share for $250,000 total.
Modular Medical posts investor presentation to website
Investor presentation posted to www.modular-medical.com on September 29, 2021.
Chief Commercial Officer Stephen Daly resigns, effective Sept 24; consulting arrangement planned
Stephen Daly resigned as Chief Commercial Officer, effective on or about September 24, 2021.
Modular Medical appoints Lynn O'Connor Vos as CEO; founder DiPerna becomes Chairman and President
Paul DiPerna resigned as CEO effective Aug 11, 2021; remains Chairman, President, CFO, Secretary.
Effective May 22, 2025, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Jeffrey Goldberg as a member of the Board.
On July 5, 2023, the Board appointed Duane DeSisto, 68, to serve as a member of the Board and to chair the Compensation Committee of the Board, effective immediately.
On July 5, 2023, William Febbo resigned from the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) effective immediately.
On July 21, 2022, the Board of Directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Kevin Schmid as Chief Operating Officer of the Company.
the Board appointed Mr. James Besser, 46, as the Company’s Chief Executive Officer
On February 23, 2022, Ellen O’Connor Vos informed the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) that she was resigning from her position as Chief Executive Officer of the Company, effective immediately
On December 31, 2021, Liam Burns resigned from his position as a member of the board of directors (the "Board") of Modular Medical, Inc. (the "Company").
Effective November 29, 2021, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Steven Felsher and Philip Sheibley as members of the Board.
Effective November 29, 2021, the board of directors (the “Board”) of Modular Medical, Inc. (the “Company”) appointed Steven Felsher and Philip Sheibley as members of the Board.
On September 14, 2021, Stephen Daly submitted his resignation as Chief Commercial Officer of Modular Medical, Inc. (the “Company”), effective on or about September 24, 2021.
Effective August 11, 2021, the Board appointed Ellen O’Connor Vos, a member of the Board since May 18, 2021, as chief executive officer of the Company.
Effective August 11, 2021, Paul DiPerna resigned as chief executive officer of Modular Medical, Inc. (the “Company”).
Max materiality 0.90 · Median 0.55 · Most common event other_material